The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 2

More JCP Articles

JCP
Thank You to the JCP Community
Editorial

January 19, 2026

Marlene P. Freeman, Editor in Chief, expresses gratitude to JCP’s editors, editorial board members, peer reviewers, authors, and readers.
JCP
Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes
Original Research

January 14, 2026

Even very low levels of opioid use in the first 2–3 weeks of buprenorphine treatment signal risk for poor outcomes.
, , , et al
JCP
The Psychedelic Renaissance and Treatment-Resistant Depression with David Feifel, MD, PhD
Podcast

January 13, 2026

,
JCP
Video Therapy Habit Reversal Training for Body-Focused Repetitive Behaviors
Original Research

January 12, 2026

Large treatment effects and improvements across the lifespan for trichotillomania and excoriation disorder suggest this delivery format may address barriers to evidence-based care.
, , , et al
JCP
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
Original Research

January 12, 2026

Innovation in psychiatric drug development in the past 13 years was limited, with most new drugs representing incremental advances rather than groundbreaking innovations.
, , , et al
JCP
Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes
Clinical and Practical Psychopharmacology

January 7, 2026

About 0.04%-0.14% of women may use pregabalin during pregnancy. This article examines outcomes of pregnancies that were exposed to gabapentin.
JCP
Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial
Brief Report

January 7, 2026

Dysphoric mood was significantly reduced after an exercise intervention that included included high-impact treadmill interval training; there were no significant changes in other general symptoms.
,
JCP
Digital Cognitive Intervention in Older People at Risk of Dementia
Original Research

January 7, 2026

A 6-month digital multi-domain intervention enhanced general cognitive function and visuospatial memory and reduced loneliness in older adults at high risk for dementia.
, , , et al
JCP
Rechallenge of Lamotrigine After Rash: A Systematic Review
Systematic Review

December 31, 2025

Lamotrigine has been rechallenged safely in select cases, but it is critical to confirm that the initial rash did not have specific features of a severe rash in order…
, , , et al
JCP
Psychiatric Hospitalization and Suicide Attempts in Healthcare Professionals
Original Research

December 31, 2025

Daily suicidal ideation and severe sleep disturbances were found to synergistically elevate suicide risk among healthcare professionals.
, , , et al
JCP
Dr Michael Asbach on the Evolution of PAs in Psychiatry
Podcast

December 30, 2025

Physician Assistant Dr. Michael Asbach addresses workforce solutions in psychiatry, from PA training and autonomous collaboration models to recent UK policy debates. Learn how interdisciplinary teams can expand access,…
,
JCP
Psychosocial Interventions and Functional Recovery in Schizophrenia
Academic Highlights

December 17, 2025

A consensus panel of experts reviewed the evidence base for use of psychosocial interventions in schizophrenia and provides practical recommendations for optimizing functional recovery.
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe